Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
By P. Benedetti Panici, S. Basile, Francesco Maneschi, Andrea Alberto Lissoni, M. Signorelli, G. Scambia, R. Angioli, S. Tateo, G. Mangili, D. Katsaros and 16 more. Journal of the National Cancer Institute, 2009
1,517 citations recorded by the source corpus.
Subfields: Obstetrics and Gynecology, Oncology, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/714ba4ec2dc1c88459813bfcc7f9736b178b74c5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Obstetrics and Gynecology
In Reproductive Medicine
Citations in the corpus
- Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. (2009, background): “Gynecologic oncologists in the United States perceive a benefit from surgicalresectionofallmetastaticcancerandtailoringpostoperativetreatment, with chemotherapy or radiation, to the pathologic findings.(24-30)”
- ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015, methodology): “In the Italian trial [95], median node counts were 26, or 30 for the 26% of patients who also had para-aortic lymphadenectomy, and there were no differences in relapse rates, disease-free survival and OS.”
- Erratum to: Endometrial Cancer (2017, background): “A randomized study has shown that in patients where systematic lymphadenectomy was performed, a higher rate of postoperative complications was detected with no improvement of disease-free and overall survival rates (Benedetti Panici et al. 2008).”
- Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. (2012, neutral): “Two other major prospective clinical trials in the Netherlands and Australia evaluating minimally invasive treatment of endometrial cancer should not be compared to this trial because of their exclusion of nonendometrioid cell types and the comprehensive staging requirement for all of the participan”
- Post operative radiation therapy in endometrial carcinoma : reducing overtreatment and improving quality of life (2013, result): “Two recent large randomised trials allocated patients to TAH-BSO with or without lymphadenectomy and found no benefit in overall and disease free survival, nor differences in rates and sites of recurrence, while lymphadenectomy was associated with higher rates of treatment related morbidity, especia”